Search

Search results

61 results found

ONL Therapeutics Announces Formation of Scientific Advisory Board

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and...

Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response.

Cruzat, Andrea, Wolfgang Schrems, Laura Schrems-Hoesl, Bernardo Cavalcanti, Neda Baniasadi, Deborah Witkin, Deborah Pavan-Langston, Reza Dana, and Pedram Hamrah. 2015. “Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response.”. Invest Ophthalmol Vis Sci 56 (11): 6612-20.